Literature DB >> 9351542

The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).

S K Gupta1, A G Douglas-Jones, N Fenn, J M Morgan, R E Mansel.   

Abstract

BACKGROUND: Mammography has greatly increased the number of women diagnosed with ductal carcinoma in situ (DCIS) of the breast. New classifications of DCIS recently have been proposed. In this study, these classifications were applied to DCIS associated with invasive tumors and correlated with patient prognosis.
METHODS: Three hundred cases of infiltrating ductal carcinoma of the breast in which there was associated DCIS in the surrounding breast were studied. The DCIS was classified as well, moderately, or poorly differentiated, according to two recently published systems using the cytonuclear features of the malignant cells (Holland classification) and cytology and the presence of necrosis (Van Nuys classification).
RESULTS: The differentiation of DCIS was significantly correlated with the grade of the invasive carcinoma (P < 0.0001), the Nottingham prognostic index (P < 0.0001), and the clinical outcomes of the patients (P < 0.0001).
CONCLUSIONS: These findings indicate that a model in which there is increasing in situ dysplasia before the development of stromal invasion is incorrect for breast carcinoma. Rather, in most cases, well-differentiated DCIS probably gives rise to low grade invasive breast carcinoma with a better long term clinical outcome. These data suggest that many of the important prognostic biologic and genetic characteristics of breast carcinoma are already established in the neoplastic clones of malignant cells at the preinvasive stage of the disease.

Entities:  

Mesh:

Year:  1997        PMID: 9351542

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.

Authors:  Vidya C Sinha; Helen Piwnica-Worms
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-07       Impact factor: 2.673

2.  Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.

Authors:  James Laird; Benjamin Lok; Chun Siu; Oren Cahlon; Atif J Khan; Beryl McCormick; Simon N Powell; Hiram Cody; Hannah Yong Wen; Alice Ho; Lior Z Braunstein
Journal:  Ann Surg Oncol       Date:  2017-11-01       Impact factor: 5.344

Review 3.  Ductal carcinoma in situ: terminology, classification, and natural history.

Authors:  D Craig Allred
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 4.  Ductal Carcinoma in Situ: Molecular Changes Accompanying Disease Progression.

Authors:  Gemma M Wilson; Phuong Dinh; Nirmala Pathmanathan; J Dinny Graham
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-05-14       Impact factor: 2.698

Review 5.  The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.

Authors:  Jaclyn A Freudenberg; Qiang Wang; Makoto Katsumata; Jeffrey Drebin; Izumi Nagatomo; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2009-05-18       Impact factor: 3.362

6.  Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast.

Authors:  Lynette S Phillips; Robert C Millikan; Jane C Schroeder; Jill S Barnholtz-Sloan; Beverly J Levine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

7.  The superficial margin of the skin-sparing mastectomy for breast carcinoma: factors predicting involvement and efficacy of additional margin sampling.

Authors:  Dengfeng Cao; Theodore N Tsangaris; Nina Kouprina; Lee Shun-Fune Wu; Charles M Balch; Russell Vang; Pedram Argani
Journal:  Ann Surg Oncol       Date:  2008-02-02       Impact factor: 5.344

8.  In vivo cell kinetics in breast carcinogenesis.

Authors:  M Bai; N J Agnantis; S Kamina; A Demou; P Zagorianakou; A Katsaraki; P Kanavaros
Journal:  Breast Cancer Res       Date:  2001-06-05       Impact factor: 6.466

9.  Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma.

Authors:  H Imamura; S Haga; T Shimizu; O Watanabe; T Kajiwara; M Aiba
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

10.  Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast.

Authors:  R R Millis; S E Pinder; K Ryder; R Howitt; S R Lakhani
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.